Anteilseigner
The Vanguard Group, Inc. (7,41 %) Avidity Partners Management LP (7,25 %) BlackRock Fund Advisors (7,12 %) Palo Alto Investors LP (4,45 %) Citadel Advisors LLC (2,71 %) Geode Capital Management LLC (2,08 %) GSA Capital Partners LLP (2,04 %) SSgA Funds Management, Inc. (1,79 %) Renaissance Technologies LLC (1,72 %) Marshall Wace LLP (1,68 %) BNP Paribas Financial (1,54 %) Delphi Ventures, Inc. (1,51 %) Adage Capital Management LP (1,45 %) Millennium Management LLC (1,34 %) C WorldWide Asset Management Fondsmæglerselskab A/ S (1,31 %) C Worldwide Asset Management Fondsmæglerselskab A/ S (Sweden) (1,31 %) Goldman Sachs & Co. LLC (Private Banking) (1,06 %) Richard A. Paulson (1,01 %) LifeSci Fund Management LLC (0,98 %)
Kontakt
Karyopharm Therapeutics Inc